Shanghai Hile Bio-tech Tangible Net Worth Ratio
Shanghai Hile Bio-tech tangible net worth ratio. Shanghai Hile Bio-tech (603718) has a Tangible Net Worth Ratio of 95.1% as of June 2026. This metric is calculated by deducting intangible assets (CN¥47.21 Million) from net assets (CN¥971.57 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 603718 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shanghai Hile Bio-tech (2011–2025)
Tangible net worth ratio of Shanghai Hile Bio-tech from 2011 to 2025. This chart shows how Shanghai Hile Bio-tech's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 95.1%, reflecting net assets of CN¥971.57 Million with intangible assets of CN¥47.21 Million CNY. See Shanghai Hile Bio-tech (603718) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Shanghai Hile Bio-tech Tangible Net Worth Ratio by Year (2011–2025)
Shanghai Hile Bio-tech tangible net worth ratio by year from 2011 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Shanghai Hile Bio-tech from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 603718 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.3% | CN¥895.97 Million | CN¥50.70 Million | CN¥1.13 Billion | ▼ -2.4 pp |
| 2024 | 96.7% | CN¥1.70 Billion | CN¥55.58 Million | CN¥1.83 Billion | ▼ 0.0 pp |
| 2023 | 96.8% | CN¥1.17 Billion | CN¥38.10 Million | CN¥1.66 Billion | ▲ +3.4 pp |
| 2022 | 93.4% | CN¥1.11 Billion | CN¥73.56 Million | CN¥1.51 Billion | ▲ +3.5 pp |
| 2021 | 89.8% | CN¥987.19 Million | CN¥100.23 Million | CN¥1.84 Billion | ▲ +1.2 pp |
| 2020 | 88.6% | CN¥962.20 Million | CN¥109.43 Million | CN¥1.79 Billion | ▼ -0.2 pp |
| 2019 | 88.8% | CN¥992.57 Million | CN¥110.90 Million | CN¥1.70 Billion | ▼ -0.2 pp |
| 2018 | 89.0% | CN¥1.03 Billion | CN¥112.69 Million | CN¥1.75 Billion | ▼ -0.3 pp |
| 2017 | 89.3% | CN¥1.07 Billion | CN¥114.68 Million | CN¥1.60 Billion | ▲ +2.1 pp |
| 2016 | 87.2% | CN¥1.01 Billion | CN¥128.73 Million | CN¥1.48 Billion | ▼ -5.9 pp |
| 2015 | 93.1% | CN¥963.31 Million | CN¥66.25 Million | CN¥1.24 Billion | ▲ +0.4 pp |
| 2014 | 92.8% | CN¥558.50 Million | CN¥40.39 Million | CN¥654.48 Million | ▲ +0.6 pp |
| 2013 | 92.1% | CN¥500.66 Million | CN¥39.37 Million | CN¥600.84 Million | ▼ -1.1 pp |
| 2012 | 93.3% | CN¥467.89 Million | CN¥31.56 Million | CN¥560.66 Million | ▲ +1.9 pp |
| 2011 | 91.3% | CN¥405.74 Million | CN¥35.23 Million | CN¥504.03 Million | — |